Gene Genie
An application to challenge the patenting of human genes that could hamper diagnostic research has been upheld by a federal judge in New York.
Sign up for Smart Faster newsletter
The most counterintuitive, surprising, and impactful new stories delivered to your inbox every Thursday.
“A federal judge ruled Monday that a lawsuit can move forward against the Patent and Trademark Office and the research company that was awarded exclusive rights to human genes known to detect early signs of breast and ovarian cancer,” reports Wired. “The first-of-its-kind lawsuit by the American Civil Liberties Union and the Public Patent Foundation at the Benjamin Cardozo School of Law claims that the patents violate free speech by restricting research. U.S. District Judge Robert W. Sweet of New York, in ruling that the case may proceed to trial, noted that the litigation might open the door to challenges of a host of other patented genes. About one-fifth of the human genome is covered under patent applications and claims.”
Sign up for Smart Faster newsletter
The most counterintuitive, surprising, and impactful new stories delivered to your inbox every Thursday.